RCMNY
ETNB

Rubric Capital Management (New York)’s 89bio ETNB Stock Holding History

Rubric Capital Management (New York)’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-989,388
Closed -$5.73M – 99
2022
Q3 		$5.73M Buy
+989,388
New +$4.35M 0.29% 61

Other funds holding ETNB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Rubric Capital Management (New York)'s ETNB Position: Q4 2022 in Review

Rubric Capital Management (New York) sold out of 89bio (ETNB) in Q4 2022, closing a stake of 989,388 shares — an estimated $5.73M sold.

Rubric Capital Management (New York) first reported a position in ETNB in Q3 2022 and held it in 1 quarter. The position peaked at $5.73M in Q3 2022. 106 funds tracked by Wall St. Rank hold ETNB as of Q4 2022.

  • Rubric Capital Management (New York) reported no remaining 89bio position as of Q4 2022 after selling out during the quarter.
  • Rubric Capital Management (New York) sold 989,388 89bio shares in Q4 2022, an estimated $5.73M.
  • Rubric Capital Management (New York) first reported a position in 89bio in Q3 2022 and held it in 1 quarter.
  • Rubric Capital Management (New York)'s 89bio position peaked at $5.73M in Q3 2022.
  • 106 funds tracked by Wall St. Rank held 89bio as of Q4 2022.

Based on Rubric Capital Management (New York)'s 13F filing for Q4 2022, filed 10 Feb 2023.